News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Yakult Honsha And OncoTherapy Science, Inc. To Team Up In R&D For New Antibody Drugs For Lung Cancer Treatments


10/19/2005 5:11:05 PM

Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments. Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES